Deutsche Bank’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.2K | Hold |
20,890
| – | – | ﹤0.01% | 3255 |
|
|
2025
Q1 | $76.2K | Buy |
20,890
+8,580
| +70% | +$31.3K | ﹤0.01% | 3252 |
|
|
2024
Q4 | $58.1K | Hold |
12,310
| – | – | ﹤0.01% | 3349 |
|
|
2024
Q3 | $115K | Buy |
12,310
+4,470
| +57% | +$41.6K | ﹤0.01% | 3128 |
|
|
2024
Q2 | $45.1K | Sell |
7,840
-1,754
| -18% | -$10.1K | ﹤0.01% | 3300 |
|
|
2024
Q1 | $64.4K | Sell |
9,594
-399
| -4% | -$2.68K | ﹤0.01% | 3289 |
|
|
2023
Q4 | $64.5K | Hold |
9,993
| – | – | ﹤0.01% | 3338 |
|
|
2023
Q3 | $50K | Hold |
9,993
| – | – | ﹤0.01% | 3383 |
|
|
2023
Q2 | $70.4K | Sell |
9,993
-2,986
| -23% | -$21K | ﹤0.01% | 3383 |
|
|
2023
Q1 | $80.5K | Buy |
12,979
+4,340
| +50% | +$26.9K | ﹤0.01% | 3403 |
|
|
2022
Q4 | $55.1K | Buy |
8,639
+136
| +2% | +$868 | ﹤0.01% | 3516 |
|
|
2022
Q3 | $73K | Sell |
8,503
-1,345
| -14% | -$11.5K | ﹤0.01% | 3434 |
|
|
2022
Q2 | $134K | Sell |
9,848
-779
| -7% | -$10.6K | ﹤0.01% | 3351 |
|
|
2022
Q1 | $162K | Sell |
10,627
-1,258
| -11% | -$19.2K | ﹤0.01% | 3348 |
|
|
2021
Q4 | $272K | Sell |
11,885
-83,055
| -87% | -$1.9M | ﹤0.01% | 3187 |
|
|
2021
Q3 | $1.32M | Sell |
94,940
-94,169
| -50% | -$1.31M | ﹤0.01% | 2421 |
|
|
2021
Q2 | $2.02M | Sell |
189,109
-33,805
| -15% | -$361K | ﹤0.01% | 2202 |
|
|
2021
Q1 | $2.94M | Buy |
222,914
+217,868
| +4,318% | +$2.87M | ﹤0.01% | 1886 |
|
|
2020
Q4 | $102K | Buy |
+5,046
| New | +$102K | ﹤0.01% | 3763 |
|